Medtronic brings legacy vessel-sealing tech to Hugo robotic platform

The LigaSure Maryland jaw device is designed to seal and cut vessels, thick tissue, and lymphatics up to 7 mm in diameter. By pairing the instrument with the Valleylab FT10 energy platform, the Hugo system can now deliver the same performance surgeons have relied on for decades in laparoscopic and open settings. According to Dr. Matthew Kroh, chief medical officer of the Surgical business at Medtronic, the move allows clinicians to maintain consistent control and confidence during the most demanding phases of a robotic operation. The technology has a significant clinical pedigree, having been deployed in over 45 million procedures across more than 65 countries over the last two decades. While the Hugo RAS system is currently cleared specifically for urologic procedures in the U.S., Medtronic continues to pursue expanded indications for general and gynecologic soft-tissue surgeries. The device’s introduction follows its 2025 European launch, marking a strategic effort by the Galway-based company to standardize its surgical toolsets across all modalities.